Non-steroidal Anti-inflammatory Drugs (NSAID) Market Report

China Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Market Research Report 2023-2029

  • POSTDATE：Aug 25, 2023
  • PAGES：164
  • REPORT CODE：GMM1754999
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Non-steroidal Anti-inflammatory Drugs (NSAID) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Generic

    • Boehringer Ingelheim

    • Elanco

    • Ecotrin

    • Merck Animal Health

    • St Joseph

    • Zoetis

    • Merial

    By Type:

    • Selective COX-2 inhibitors (Coxibs)

    • Propionic acid derivatives

    • Sulfonanilides

    • Enolic acid (Oxicam) derivatives

    • Acetic acid derivatives

    • Anthranilic acid derivatives (Fenamates)

    • Salicylates

    By Application:

    • Others

    • Human

    • Animals

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Overview 2018-2029

    • 1.1 China Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Development Overview

    • 1.2 China Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Development History

    • 1.3 China Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Market Size (2018-2029)

    • 1.4 China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Analysis by Type from Production Side

      • 1.4.1 China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume, Production Value and Growth Rate of Selective COX-2 inhibitors (Coxibs) (2018-2029)

      • 1.4.2 China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume, Production Value and Growth Rate of Propionic acid derivatives (2018-2029)

      • 1.4.3 China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume, Production Value and Growth Rate of Sulfonanilides (2018-2029)

      • 1.4.4 China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume, Production Value and Growth Rate of Enolic acid (Oxicam) derivatives (2018-2029)

      • 1.4.5 China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume, Production Value and Growth Rate of Acetic acid derivatives (2018-2029)

      • 1.4.6 China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume, Production Value and Growth Rate of Anthranilic acid derivatives (Fenamates) (2018-2029)

      • 1.4.7 China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume, Production Value and Growth Rate of Salicylates (2018-2029)

    • 1.5 China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Analysis by Application from Consumption End

      • 1.5.1 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.2 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Sales Value and Growth Rate of Human (2018-2029)

      • 1.5.3 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Sales Value and Growth Rate of Animals (2018-2029)

    • 1.6 China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Analysis by Region

      • 1.6.1 North China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate from 2018-2029

    Chapter 2 China Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Non-steroidal Anti-inflammatory Drugs (NSAID) Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Status and Competition Analysis in 2023

      • 2.2.3 China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Non-steroidal Anti-inflammatory Drugs (NSAID) Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Development

    Chapter 3 Non-steroidal Anti-inflammatory Drugs (NSAID)Industry Chain Analysis

    • 3.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Chain

    • 3.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Non-steroidal Anti-inflammatory Drugs (NSAID) Market

    • 3.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Non-steroidal Anti-inflammatory Drugs (NSAID) Market

    Chapter 4 China Non-steroidal Anti-inflammatory Drugs (NSAID) Market, by Type

    • 4.1 China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Non-steroidal Anti-inflammatory Drugs (NSAID) Total Production Volume and Growth Rate from Production Side

    • 4.5 China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume and Growth Rate, by Type

      • 4.5.1 China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume and Growth Rate of Selective COX-2 inhibitors (Coxibs)

      • 4.5.2 China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume and Growth Rate of Propionic acid derivatives

      • 4.5.3 China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume and Growth Rate of Sulfonanilides

      • 4.5.4 China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume and Growth Rate of Enolic acid (Oxicam) derivatives

      • 4.5.5 China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume and Growth Rate of Acetic acid derivatives

      • 4.5.6 China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume and Growth Rate of Anthranilic acid derivatives (Fenamates)

      • 4.5.7 China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume and Growth Rate of Salicylates

    Chapter 5 China Non-steroidal Anti-inflammatory Drugs (NSAID) Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Non-steroidal Anti-inflammatory Drugs (NSAID) Total Market Size and Growth Rate from Consumption End

    • 5.5 China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate, by Application

      • 5.5.1 China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate of Others

      • 5.5.2 China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate of Human

      • 5.5.3 China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate of Animals

    Chapter 6 China Non-steroidal Anti-inflammatory Drugs (NSAID) Market, by Region

    • 6.1 China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume and Production Value, by Region

    • 6.2 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume and Sales Value, by Region

    Chapter 7 North China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Analysis

    • 7.1 North China Non-steroidal Anti-inflammatory Drugs (NSAID) Market, by Type

    • 7.2 North China Non-steroidal Anti-inflammatory Drugs (NSAID) Market, by Application

    Chapter 8 Central China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Analysis

    • 8.1 Central China Non-steroidal Anti-inflammatory Drugs (NSAID) Market, by Type

    • 8.2 Central China Non-steroidal Anti-inflammatory Drugs (NSAID) Market, by Application

    Chapter 9 South China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Analysis

    • 9.1 South China Non-steroidal Anti-inflammatory Drugs (NSAID) Market, by Type

    • 9.2 South China Non-steroidal Anti-inflammatory Drugs (NSAID) Market, by Application

    Chapter 10 East China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Analysis

    • 10.1 East China Non-steroidal Anti-inflammatory Drugs (NSAID) Market, by Type

    • 10.2 East China Non-steroidal Anti-inflammatory Drugs (NSAID) Market, by Application

    Chapter 11 Northeast China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Analysis

    • 11.1 Northeast China Non-steroidal Anti-inflammatory Drugs (NSAID) Market, by Type

    • 11.2 Northeast China Non-steroidal Anti-inflammatory Drugs (NSAID) Market, by Application

    Chapter 12 Southwest China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Analysis

    • 12.1 Southwest China Non-steroidal Anti-inflammatory Drugs (NSAID) Market, by Type

    • 12.2 Southwest China Non-steroidal Anti-inflammatory Drugs (NSAID) Market, by Application

    Chapter 13 Northwest China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Analysis

    • 13.1 Northwest China Non-steroidal Anti-inflammatory Drugs (NSAID) Market, by Type

    • 13.2 Northwest China Non-steroidal Anti-inflammatory Drugs (NSAID) Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Generic

        • 14.1.1 Generic Company Profile

        • 14.1.2 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Boehringer Ingelheim

        • 14.2.1 Boehringer Ingelheim Company Profile

        • 14.2.2 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Elanco

        • 14.3.1 Elanco Company Profile

        • 14.3.2 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Ecotrin

        • 14.4.1 Ecotrin Company Profile

        • 14.4.2 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Merck Animal Health

        • 14.5.1 Merck Animal Health Company Profile

        • 14.5.2 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 St Joseph

        • 14.6.1 St Joseph Company Profile

        • 14.6.2 St Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Zoetis

        • 14.7.1 Zoetis Company Profile

        • 14.7.2 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Merial

        • 14.8.1 Merial Company Profile

        • 14.8.2 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Market Performance

        • 14.8.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Research Conclusions

    • 15.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Market Size (2018-2029)

    • Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume, Production Value and Growth Rate of Selective COX-2 inhibitors (Coxibs) (2018-2029)

    • Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume, Production Value and Growth Rate of Propionic acid derivatives (2018-2029)

    • Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume, Production Value and Growth Rate of Sulfonanilides (2018-2029)

    • Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume, Production Value and Growth Rate of Enolic acid (Oxicam) derivatives (2018-2029)

    • Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume, Production Value and Growth Rate of Acetic acid derivatives (2018-2029)

    • Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume, Production Value and Growth Rate of Anthranilic acid derivatives (Fenamates) (2018-2029)

    • Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume, Production Value and Growth Rate of Salicylates (2018-2029)

    • Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Sales Value and Growth Rate of Human (2018-2029)

    • Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume, Sales Value and Growth Rate of Animals (2018-2029)

    • Figure North China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate from 2018-2029

    • Figure Central China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate from 2018-2029

    • Figure South China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate from 2018-2029

    • Figure East China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate from 2018-2029

    • Figure Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Type in 2018

    • Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Type in 2023

    • Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume and Growth Rate of Selective COX-2 inhibitors (Coxibs) (2018-2023)

    • Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume and Growth Rate of Propionic acid derivatives (2018-2023)

    • Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume and Growth Rate of Sulfonanilides (2018-2023)

    • Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume and Growth Rate of Enolic acid (Oxicam) derivatives (2018-2023)

    • Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume and Growth Rate of Acetic acid derivatives (2018-2023)

    • Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume and Growth Rate of Anthranilic acid derivatives (Fenamates) (2018-2023)

    • Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume and Growth Rate of Salicylates (2018-2023)

    • Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Application in 2018

    • Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Application in 2023

    • Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Total Market Size and Growth Rate from Consumption End

    • Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate of Others (2018-2023)

    • Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate of Human (2018-2023)

    • Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate of Animals (2018-2023)

    • Table China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume by Region (2018-2023)

    • Table China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume Share by Region (2018-2023)

    • Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume Share by Region (2018-2023)

    • Table China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Value by Region (2018-2023)

    • Table China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Value Share by Region (2018-2023)

    • Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Value Share by Region (2018-2023)

    • Table China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Region (2018-2023)

    • Table China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Share by Region (2018-2023)

    • Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Share by Region (2018-2023)

    • Table China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value by Region (2018-2023)

    • Table China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value Share by Region (2018-2023)

    • Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Value Share by Region (2018-2023)

    • Table North China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume by Type (2018-2023)

    • Table North China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume Share by Type (2018-2023)

    • Figure North China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume Share by Type (2018-2023)

    • Table North China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Application (2018-2023)

    • Table North China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Share by Application (2018-2023)

    • Figure North China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Share by Application (2018-2023)

    • Table Central China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume by Type (2018-2023)

    • Table Central China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume Share by Type (2018-2023)

    • Figure Central China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume Share by Type (2018-2023)

    • Table Central China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Application (2018-2023)

    • Table Central China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Share by Application (2018-2023)

    • Figure Central China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Share by Application (2018-2023)

    • Table South China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume by Type (2018-2023)

    • Table South China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume Share by Type (2018-2023)

    • Figure South China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume Share by Type (2018-2023)

    • Table South China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Application (2018-2023)

    • Table South China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Share by Application (2018-2023)

    • Figure South China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Share by Application (2018-2023)

    • Table East China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume by Type (2018-2023)

    • Table East China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume Share by Type (2018-2023)

    • Figure East China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume Share by Type (2018-2023)

    • Table East China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Application (2018-2023)

    • Table East China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Share by Application (2018-2023)

    • Figure East China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Share by Application (2018-2023)

    • Table Northeast China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume by Type (2018-2023)

    • Table Northeast China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume Share by Type (2018-2023)

    • Figure Northeast China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume Share by Type (2018-2023)

    • Table Northeast China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Application (2018-2023)

    • Table Northeast China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Share by Application (2018-2023)

    • Table Southwest China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume by Type (2018-2023)

    • Table Southwest China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume Share by Type (2018-2023)

    • Figure Southwest China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume Share by Type (2018-2023)

    • Table Southwest China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Application (2018-2023)

    • Table Southwest China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Share by Application (2018-2023)

    • Table Northwest China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume by Type (2018-2023)

    • Table Northwest China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume Share by Type (2018-2023)

    • Figure Northwest China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Volume Share by Type (2018-2023)

    • Table Northwest China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume by Application (2018-2023)

    • Table Northwest China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Share by Application (2018-2023)

    • Table Generic Company Profile

    • Table Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, Price and Gross (2018-2023)

    • Table Boehringer Ingelheim Company Profile

    • Table Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, Price and Gross (2018-2023)

    • Table Elanco Company Profile

    • Table Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, Price and Gross (2018-2023)

    • Table Ecotrin Company Profile

    • Table Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, Price and Gross (2018-2023)

    • Table Merck Animal Health Company Profile

    • Table Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, Price and Gross (2018-2023)

    • Table St Joseph Company Profile

    • Table St Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, Price and Gross (2018-2023)

    • Table Zoetis Company Profile

    • Table Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, Price and Gross (2018-2023)

    • Table Merial Company Profile

    • Table Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US